论文部分内容阅读
目的:分析普米克气雾剂在儿童哮喘疾病中的治疗效果。方法:将我院2011年3月-2013年6月接收儿童哮喘中抽选疾病患儿60例作为研究对象,分成不同疗法治疗组,其中:对照组患儿行基础疗法,实验组患儿行普米克气雾剂疗法,评判疾病效果。结果:实验组哮喘疾病患儿临床治疗效果(96.7%)、临床指标(咳嗽、喘息、肺啰音等)和对照组(73.3%)相比,差异明显(P<0.05)。结论:临床借助普米克气雾剂治疗儿童哮喘疾病作用明显,可加快疾病症状消退进度,提高临床治愈率,值得使用。
OBJECTIVE: To analyze the therapeutic effect of Pulmicort aerosol in children with asthma. Methods: From March 2011 to June 2013, 60 cases of children with asthma receiving selected children asthma were divided into different treatment groups, including: the control group of children underwent basic therapy, the experimental group of children Pulmicort aerosol therapy to judge the effect of the disease. Results: The clinical efficacy of the treatment group (96.7%) was significantly lower than that of the control group (73.3%) (P <0.05). The clinical indicators (cough, wheezing, pulmonary rales, etc. Conclusion: The clinical use of Pulmicort aerosol treatment of children with asthma has obvious effect, can accelerate the progress of disease symptoms and improve the clinical cure rate, it is worth using.